Safety Concern About Carnitine by Dr. Deneb Bates

New research suggests that, for certain people, taking carnitine supplements might increase the risk of cardiovascular disease. If you are taking acetyl-L-carnitine (Carnityl), please schedule an appointment with Dr. Bates to assess your individual risks and benefits from taking this supplement.

CombiRx Trial by Dr. James W. Stark

Results of a large multicenter treatment trial, called CombiRx, were recently published online in the journal Annals of Neurology. This trial examined whether combination treatment with copaxone and interferonβ-1a together is more effective than each treatment alone. Although the primary results showed no clinical benefit to combination therapy, there were no additional safety concerns.

Subscribe to RSS - Research